4
Changes in Ownership
PALVELLA THERAPEUTICS, INC. Filed Acc 0001437749-23-004948
Options or other derivatives
- Chief Development Officer acquired 249,080 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Olwill Shane · Chief Development Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-24 | Grant or award : show line 1 in the form Stock Option (Right to buy) | +249,080 | 249,080 | D |
Loading xslF345X03/rdgdoc.xml…